SYNTap Biomarker Test to Aid Early Parkinson’s Diagnosis Available in US

SYNTap Biomarker Test to Aid Early Parkinson’s Diagnosis Available in US

308420

SYNTap Biomarker Test to Aid Early Parkinson’s Diagnosis Available in US

Amprion has announced the commercial rollout of SYNTap Biomarker Test, a laboratory test to accurately detect alpha-synuclein aggregates, a hallmark of various brain diseases, including Parkinson’s disease. Alpha-synuclein, a protein, can misfold and accumulate (aggregate) in toxic clumps called Lewy bodies, leading to the death of nerve cells. In Parkinson’s, the affected brain cells produce dopamine, the signaling molecule used to send messages between nerve cells that control body movements. Alpha-synuclein aggregates, also referred to…

You must be logged in to read/download the full post.